These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23255405)

  • 1. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.
    Fagan-Solis KD; Schneider SS; Pentecost BT; Bentley BA; Otis CN; Gierthy JF; Arcaro KF
    J Cell Biochem; 2013 Jun; 114(6):1385-94. PubMed ID: 23255405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
    Jiang J
    Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.
    Gozgit JM; Pentecost BT; Marconi SA; Otis CN; Wu C; Arcaro KF
    Mol Cancer Res; 2006 Dec; 4(12):905-13. PubMed ID: 17189381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
    Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
    Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
    Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.
    Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
    Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2, -9, FAK, Rho A and Rock-1 gene expression.
    Lin HJ; Su CC; Lu HF; Yang JS; Hsu SC; Ip SW; Wu JJ; Li YC; Ho CC; Wu CC; Chung JG
    Oncol Rep; 2010 Mar; 23(3):665-70. PubMed ID: 20127004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
    Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
    Paduch R; Kandefer-Szerszeń M; Szuster-Ciesielska A; Plewka K
    Cell Biol Int; 2010 Jan; 34(2):213-23. PubMed ID: 19947919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.
    Nilsson UW; Garvin S; Dabrosin C
    Breast Cancer Res Treat; 2007 May; 102(3):253-61. PubMed ID: 17031577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion.
    Hodge JC; Bub J; Kaul S; Kajdacsy-Balla A; Lindholm PF
    Cancer Res; 2003 Mar; 63(6):1359-64. PubMed ID: 12649199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors.
    Privat M; Cavard A; Zekri Y; Ponelle-Chachuat F; Molnar I; Sonnier N; Bignon YJ
    Int J Med Sci; 2020; 17(17):2799-2808. PubMed ID: 33162807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RhoA expression prevents proliferation and metastasis of SPCA1 lung cancer cells in vitro.
    Yang X; Zheng F; Zhang S; Lu J
    Biomed Pharmacother; 2015 Feb; 69():361-6. PubMed ID: 25661383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin rescues breast cells from epithelial‑mesenchymal transition and invasion induced by anti‑miR‑34a.
    Gallardo M; Kemmerling U; Aguayo F; Bleak TC; Muñoz JP; Calaf GM
    Int J Oncol; 2020 Feb; 56(2):480-493. PubMed ID: 31894298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical impact of new treatments in breast cancer.
    Alkatout I; Order B; Klapper W; Weigel MT; Jonat W; Schaefer FK; Mundhenke C; Wenners A
    Minerva Ginecol; 2013 Aug; 65(4):363-83. PubMed ID: 24051938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.